These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 23342042

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo.
    Fan C, Zheng W, Fu X, Li X, Wong YS, Chen T.
    Cell Death Dis; 2014 Apr 24; 5(4):e1191. PubMed ID: 24763048
    [Abstract] [Full Text] [Related]

  • 3. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.
    Wang H, Bouzakoura S, de Mey S, Jiang H, Law K, Dufait I, Corbet C, Verovski V, Gevaert T, Feron O, Van den Berge D, Storme G, De Ridder M.
    Oncotarget; 2017 May 30; 8(22):35728-35742. PubMed ID: 28415723
    [Abstract] [Full Text] [Related]

  • 4. Selenocysteine induces apoptosis in human glioma cells: evidence for TrxR1-targeted inhibition and signaling crosstalk.
    Fan CD, Fu XY, Zhang ZY, Cao MZ, Sun JY, Yang MF, Fu XT, Zhao SJ, Shao LR, Zhang HF, Yang XY, Sun BL.
    Sci Rep; 2017 Jul 25; 7(1):6465. PubMed ID: 28743999
    [Abstract] [Full Text] [Related]

  • 5. Potential Anticancer Activity of Auranofin.
    Onodera T, Momose I, Kawada M.
    Chem Pharm Bull (Tokyo); 2019 Jul 25; 67(3):186-191. PubMed ID: 30827998
    [Abstract] [Full Text] [Related]

  • 6. Auranofin, an inhibitor of thioredoxin reductase, induces apoptosis in hepatocellular carcinoma Hep3B cells by generation of reactive oxygen species.
    Hwang-Bo H, Jeong JW, Han MH, Park C, Hong SH, Kim GY, Moon SK, Cheong J, Kim WJ, Yoo YH, Choi YH.
    Gen Physiol Biophys; 2017 Apr 25; 36(2):117-128. PubMed ID: 28218611
    [Abstract] [Full Text] [Related]

  • 7. Natural borneol, a monoterpenoid compound, potentiates selenocystine-induced apoptosis in human hepatocellular carcinoma cells by enhancement of cellular uptake and activation of ROS-mediated DNA damage.
    Su J, Lai H, Chen J, Li L, Wong YS, Chen T, Li X.
    PLoS One; 2013 Apr 25; 8(5):e63502. PubMed ID: 23700426
    [Abstract] [Full Text] [Related]

  • 8. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
    Raninga PV, Di Trapani G, Vuckovic S, Tonissen KF.
    Redox Biol; 2016 Aug 25; 8():175-85. PubMed ID: 26795735
    [Abstract] [Full Text] [Related]

  • 9. Maintenance of S-nitrosothiol homeostasis plays an important role in growth suppression of estrogen receptor-positive breast tumors.
    Cañas A, López-Sánchez LM, Valverde-Estepa A, Hernández V, Fuentes E, Muñoz-Castañeda JR, López-Pedrera C, De La Haba-Rodríguez JR, Aranda E, Rodríguez-Ariza A.
    Breast Cancer Res; 2012 Dec 05; 14(6):R153. PubMed ID: 23216744
    [Abstract] [Full Text] [Related]

  • 10. Morin enhances auranofin anticancer activity by up-regulation of DR4 and DR5 and modulation of Bcl-2 through reactive oxygen species generation in Hep3B human hepatocellular carcinoma cells.
    Hwang-Bo H, Lee WS, Nagappan A, Kim HJ, Panchanathan R, Park C, Chang SH, Kim ND, Leem SH, Chang YC, Kwon TK, Cheong JH, Kim GS, Jung JM, Shin SC, Hong SC, Choi YH.
    Phytother Res; 2019 May 05; 33(5):1384-1393. PubMed ID: 30887612
    [Abstract] [Full Text] [Related]

  • 11. Synergistic induction of apoptosis by combination treatment with mesupron and auranofin in human breast cancer cells.
    Lee JE, Kwon YJ, Baek HS, Ye DJ, Cho E, Choi HK, Oh KS, Chun YJ.
    Arch Pharm Res; 2017 Jun 05; 40(6):746-759. PubMed ID: 28560500
    [Abstract] [Full Text] [Related]

  • 12. Selenocystine induces S-phase arrest and apoptosis in human breast adenocarcinoma MCF-7 cells by modulating ERK and Akt phosphorylation.
    Chen T, Wong YS.
    J Agric Food Chem; 2008 Nov 26; 56(22):10574-81. PubMed ID: 18959417
    [Abstract] [Full Text] [Related]

  • 13. Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation.
    Chen T, Wong YS.
    Int J Biochem Cell Biol; 2009 Mar 26; 41(3):666-76. PubMed ID: 18718551
    [Abstract] [Full Text] [Related]

  • 14. In vitro antineoplastic effects of auranofin in canine lymphoma cells.
    Zhang H, Rose BJ, Pyuen AA, Thamm DH.
    BMC Cancer; 2018 May 03; 18(1):522. PubMed ID: 29724201
    [Abstract] [Full Text] [Related]

  • 15. Ruthenium(II) salicylate complexes inducing ROS-mediated apoptosis by targeting thioredoxin reductase.
    Chen JC, Zhang Y, Jie XM, She J, Dongye GZ, Zhong Y, Deng YY, Wang J, Guo BY, Chen LM.
    J Inorg Biochem; 2019 Apr 03; 193():112-123. PubMed ID: 30711557
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of thioredoxin reductase by auranofin induces apoptosis in adriamycin-resistant human K562 chronic myeloid leukemia cells.
    Liu JJ, Liu Q, Wei HL, Yi J, Zhao HS, Gao LP.
    Pharmazie; 2011 Jun 03; 66(6):440-4. PubMed ID: 21699084
    [Abstract] [Full Text] [Related]

  • 17. Discovery of novel organoarsenicals as robust thioredoxin reductase inhibitors for oxidative stress mediated cancer therapy.
    She W, Shi X, Liu T, Liu Y, Liu Y.
    Biochem Pharmacol; 2023 Dec 03; 218():115908. PubMed ID: 37931662
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of thioredoxin reductase (TrxR) triggers oxidative stress-induced apoptosis in filarial nematode Setaria cervi channelized through ASK-1-p38 mediated caspase activation.
    Joardar N, Sen A, Rath J, Babu SPS.
    Mol Biochem Parasitol; 2021 Mar 03; 242():111364. PubMed ID: 33639230
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer.
    Raninga PV, Lee AC, Sinha D, Shih YY, Mittal D, Makhale A, Bain AL, Nanayakarra D, Tonissen KF, Kalimutho M, Khanna KK.
    Int J Cancer; 2020 Jan 01; 146(1):123-136. PubMed ID: 31090219
    [Abstract] [Full Text] [Related]

  • 20. Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
    Kaminska KK, Bertrand HC, Tajima H, Stafford WC, Cheng Q, Chen W, Wells G, Arner ES, Chew EH.
    Oncotarget; 2016 Jun 28; 7(26):40233-40251. PubMed ID: 27244886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.